Emancipator, Kenneth http://orcid.org/0000-0002-6629-4430
Huang, Lingkang
Aurora-Garg, Deepti
Bal, Tricia
Cohen, Ezra E.W.
Harrington, Kevin http://orcid.org/0000-0002-6014-348X
Soulières, Denis
Le Tourneau, Christophe
Licitra, Lisa
Burtness, Barbara
Swaby, Ramona
Funding for this research was provided by:
Merck (N/A, N/A, N/A, N/A, N/A, N/A)
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
This article is maintained by: Elsevier
Article Title: Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer
Journal Title: Modern Pathology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-020-00710-9
Content Type: article
Copyright: © 2020 United States & Canadian Academy of Pathology.